{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:24:35Z","timestamp":1788805475775,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["GM119522"],"award-info":[{"award-number":["GM119522"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WA3786\/2-1"],"award-info":[{"award-number":["WA3786\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WA3786\/3-1"],"award-info":[{"award-number":["WA3786\/3-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.lfs.2021.119925","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T10:56:45Z","timestamp":1630493805000},"page":"119925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Development of heart failure with preserved ejection fraction in type 2 diabetic mice is ameliorated by preserving vascular function"],"prefix":"10.1016","volume":"284","author":[{"given":"Mandy","family":"Otto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Brabenec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Kintrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina E.M.","family":"Hellenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Holtmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie Charlotte","family":"Steinbuch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole S\u00f6nken","family":"Karsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heorhii","family":"Pryvalov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Rossaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric R.","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana-Maria","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.lfs.2021.119925_bb0005","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMsa2032271","article-title":"Trends in diabetes management among US adults: 1999\u20132018","volume":"384","author":"Fang","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.lfs.2021.119925_bb0010","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/1479164118787415","article-title":"The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: a systematic review and meta-analysis","volume":"15","author":"Bouthoorn","year":"2018","journal-title":"Diabetes Vasc. Dis. Res."},{"issue":"20","key":"10.1016\/j.lfs.2021.119925_bb0015","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1093\/eurheartj\/ehm037","article-title":"How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the European Society of Cardiology","volume":"28","author":"Paulus","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.lfs.2021.119925_bb0020","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3389\/fphys.2019.01347","article-title":"Microvascular dysfunction in heart failure with preserved ejection fraction","volume":"10","author":"D\u2019Amario","year":"2019","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.lfs.2021.119925_bb0025","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1056\/NEJMoa052256","article-title":"Trends in prevalence and outcome of heart failure with preserved ejection fraction","volume":"355","author":"Owan","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.lfs.2021.119925_bb0030","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1093\/eurheartj\/ehq426","article-title":"Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment","volume":"32","author":"Borlaug","year":"2011","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.lfs.2021.119925_bb0035","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/CIRCULATIONAHA.110.014506","article-title":"Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes MellitusClinical perspective","volume":"124","author":"Shenouda","year":"2011","journal-title":"Circulation"},{"issue":"5708","key":"10.1016\/j.lfs.2021.119925_bb0040","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1126\/science.1104343","article-title":"Mitochondrial dysfunction and type 2 diabetes","volume":"307","author":"Lowell","year":"2005","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.lfs.2021.119925_bb0045","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/hh0701.088838","article-title":"Adenoviral delivery of a leukocyte-type 12 lipoxygenase ribozyme inhibits effects of glucose and platelet-derived growth factor in vascular endothelial and smooth muscle cells","volume":"88","author":"Patricia","year":"2001","journal-title":"Circ. Res."},{"issue":"9","key":"10.1016\/j.lfs.2021.119925_bb0050","doi-asserted-by":"crossref","first-page":"4999","DOI":"10.1172\/JCI136621","article-title":"12 (S)-HETE mediates diabetes induced endothelial dysfunction by activating intracellular endothelial cell TRPV1","volume":"130","author":"Otto","year":"2020","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.lfs.2021.119925_bb0055","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/dme.13177","article-title":"Elevated 12-hydroxyeicosatetraenoic acid (12-HETE) levels in serum of individuals with newly diagnosed Type 1 diabetes","volume":"34","author":"Hennessy","year":"2016","journal-title":"Diabet. Med."},{"issue":"6","key":"10.1016\/j.lfs.2021.119925_bb0060","first-page":"385","article-title":"12S-hydroxyeicosatetraenoic acid levels link to coronary artery disease in type 2 diabetic patients","volume":"36","author":"Zhang","year":"2013","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.lfs.2021.119925_bb0065","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.pharmthera.2018.10.010","article-title":"Role of the 12-lipoxygenase pathway in diabetes pathogenesis and complications","volume":"195","author":"Dobrian","year":"2019","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.lfs.2021.119925_bb0070","article-title":"Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction","volume":"315","author":"Alex","year":"2018","journal-title":"Am. J. Phys. Heart Circ. Phys."},{"issue":"5","key":"10.1016\/j.lfs.2021.119925_bb0075","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006609","article-title":"Phosphodiesterase 9a inhibition in mouse models of diastolic dysfunction","volume":"13","author":"Methawasin","year":"2020","journal-title":"Circ. Heart Fail."},{"issue":"6","key":"10.1016\/j.lfs.2021.119925_bb0080","first-page":"770","article-title":"Murine models of heart failure with preserved ejection fraction: a \u201cfishing expedition\u201d","volume":"2","author":"Valero-Mu\u00f1oz","year":"2017","journal-title":"Basic Transl. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2021.119925_bb0085","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/aps.2017.52","article-title":"A novel and quick PCR-based method to genotype mice with a leptin receptor mutation (db\/db mice)","volume":"39","author":"Peng","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.lfs.2021.119925_bb0090","series-title":"Probe Reports From the NIH Molecular Libraries Program [Internet]","article-title":"Discovery of ML351, a potent and selective inhibitor of human 15-lipoxygenase-1","author":"Rai","year":"2014"},{"issue":"9","key":"10.1016\/j.lfs.2021.119925_bb0095","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003774","article-title":"Transient receptor potential vanilloid 1 regulates mitochondrial membrane potential and myocardial reperfusion injury","volume":"5","author":"Hurt","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"36","key":"10.1016\/j.lfs.2021.119925_bb0100","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.1093\/eurheartj\/ehs218","article-title":"Heart rate reduction by I f-inhibition improves vascular stiffness and left ventricular systolic and diastolic function in a mouse model of heart failure with preserved ejection fraction","volume":"34","author":"Reil","year":"2013","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.lfs.2021.119925_bb0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/eurjhf\/hfq121","article-title":"Epidemiology and clinical course of heart failure with preserved ejection fraction","volume":"13","author":"Lam","year":"2011","journal-title":"Eur. J. Heart Fail."},{"issue":"7","key":"10.1016\/j.lfs.2021.119925_bb0110","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ejhf.304","article-title":"Heart failure with preserved ejection fraction: uncertainties and dilemmas","volume":"17","author":"Ferrari","year":"2015","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.lfs.2021.119925_bb0115","first-page":"1","article-title":"Distinctive patterns of inflammation across the heart failure syndrome","author":"Schiattarella","year":"2020","journal-title":"Heart Fail. Rev."},{"issue":"1","key":"10.1016\/j.lfs.2021.119925_bb0120","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0735-1097(99)00168-0","article-title":"Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery","volume":"34","author":"Kawano","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"issue":"5","key":"10.1016\/j.lfs.2021.119925_bb0125","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ejhf.2010","article-title":"Coronary microvascular dysfunction is associated with exertional haemodynamic abnormalities in patients with heart failure with preserved ejection fraction","volume":"23","author":"Ahmad","year":"2021","journal-title":"Eur. J. Heart Fail."},{"issue":"7752","key":"10.1016\/j.lfs.2021.119925_bb0130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.lfs.2021.119925_bb0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11897-016-0277-9","article-title":"The nitrate-nitrite-NO pathway and its implications for heart failure and preserved ejection fraction","volume":"13","author":"Chirinos","year":"2016","journal-title":"Curr. Heart Fail. Rep."},{"key":"10.1016\/j.lfs.2021.119925_bb0140","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.645109","article-title":"Vascular dysfunction in diabetes and obesity: focus on TRP channels","volume":"12","author":"Moraes","year":"2021","journal-title":"Front. Physiol."},{"issue":"11","key":"10.1016\/j.lfs.2021.119925_bb0145","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1073\/pnas.97.11.6155","article-title":"Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances","volume":"97","author":"Hwang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.lfs.2021.119925_bb0150","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/cvr\/cvaa123","article-title":"Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Ga oxidation","volume":"117","author":"Kolijn","year":"2021","journal-title":"Cardiovasc. Res."},{"issue":"2","key":"10.1016\/j.lfs.2021.119925_bb0155","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCHEARTFAILURE.113.000672","article-title":"Angiotensin 1\u20137 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db\/db mice by reducing lipotoxicity and inflammation","volume":"7","author":"Mori","year":"2014","journal-title":"Circ. Heart Fail."},{"issue":"2","key":"10.1016\/j.lfs.2021.119925_bb0160","first-page":"129","article-title":"Mast cells participate in the development of diastolic dysfunction in diabetic obese mice","volume":"62","author":"Guimbal","year":"2014","journal-title":"bioRxiv"},{"issue":"2","key":"10.1016\/j.lfs.2021.119925_bb0165","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1369\/0022155413513589","article-title":"Vanilloid receptor-1 (TRPV1) expression and function in the vasculature of the rat","volume":"62","author":"Toth","year":"2014","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.lfs.2021.119925_bb0170","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.lfs.2015.12.036","article-title":"Cardioprotective effects of baicalein on heart failure via modulation of Ca2+ handling proteins in vivo and in vitro","volume":"145","author":"Zhao","year":"2016","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.lfs.2021.119925_bb0175","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41577-019-0147-2","article-title":"Pain and immunity: implications for host defence","volume":"19","author":"Baral","year":"2019","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2021.119925_bb0180","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1084\/jem.20171274","article-title":"Cardiac macrophages promote diastolic dysfunction","volume":"215","author":"Hulsmans","year":"2018","journal-title":"J. Exp. Med."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521009127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521009127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:44:53Z","timestamp":1777423493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521009127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":36,"alternative-id":["S0024320521009127"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119925","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of heart failure with preserved ejection fraction in type 2 diabetic mice is ameliorated by preserving vascular function","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119925","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119925"}}